GlassScriptPhysician profile
Sarah Ford
NPI 1780044016
$2,792.48
in general payments reported to CMS, 2019-2025
23 companies · $610 in 2025
The $610 reported for 2025 was more than what 78% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $492 · 2022: $645 · 2023: $624 · 2024: $421 · 2025: $610.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,655.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $806.68 | 2021-2025 | Belbuca, Xtampza |
| Abbvie INC. | $541.84 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $313.05 | 2021-2024 | Relistor |
| Scilex Pharmaceuticals INC. | $309.42 | 2021-2025 | Ztlido |
| Pfizer INC. | $154.39 | 2021-2025 | |
| Averitas Pharma INC. | $131.44 | 2023-2024 | Qutenza |
| Grt US Holding, INC. | $86.25 | 2022 | |
| Lilly USA, LLC | $71.01 | 2022-2023 | Emgality, Reyvow |
| Novo Nordisk INC | $57.47 | 2021-2025 | Wegovy |
| Nevro Corp. | $43.63 | 2023-2024 | Senza |
| Ibsa Pharma INC. | $31.28 | 2021 | |
| Tonix Medicines, INC. | $30.62 | 2025 | Tonmya |
| Merz Pharmaceuticals, LLC | $25.61 | 2025 | Xeomin |
| Antares Pharma, INC. | $25.06 | 2024 | Xyosted |
| Impel Pharmaceuticals INC. | $22.53 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $22.37 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $21.32 | 2025 | Dysport |
| Boston Scientific Corporation | $20.13 | 2025 | Wavewriter Alpha Prime 16 |
| Halozyme INC | $19.82 | 2023 | |
| Mdd US Operations, LLC | $15.54 | 2022 | |
| Amgen INC. | $14.75 | 2024 | Prolia, Evenity |
| Allergan, INC. | $14.54 | 2021 | |
| Redhill Biopharma INC. | $13.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Ford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.